Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Authors not listed

Asociación para Evitar la Ceguera en México · 2006

Abstract

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2006). Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME). <em>Asociación para Evitar la Ceguera en México</em>. https://clinicaltrials.gov/study/NCT00406172
Vancouver
Anonymous. Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME). Asociación para Evitar la Ceguera en México. 2006.
BibTeX
@misc{anon2006Intrav, title = {Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)}, author = {Anonymous}, journal = {Asociación para Evitar la Ceguera en México}, year = {2006}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings